These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
135 related items for PubMed ID: 1512674
1. The Ego Impairment Index and schizophrenia: a validation study. Perry W, Viglione D, Braff D. J Pers Assess; 1992 Aug; 59(1):165-75. PubMed ID: 1512674 [Abstract] [Full Text] [Related]
2. The Rorschach Ego Impairment Index in heterogeneous psychiatric patients. Adrian C, Kaser-Boyd N. J Pers Assess; 1995 Dec; 65(3):408-14. PubMed ID: 8609582 [Abstract] [Full Text] [Related]
3. Refinements in the Rorschach Ego Impairment Index incorporating the human representational variable. Viglione DJ, Perry W, Meyer G. J Pers Assess; 2003 Oct; 81(2):149-56. PubMed ID: 12946921 [Abstract] [Full Text] [Related]
4. The use of the Ego Impairment Index across the schizophrenia spectrum. Perry W, Minassian A, Cadenhead K, Sprock J, Braff D. J Pers Assess; 2003 Feb; 80(1):50-7. PubMed ID: 12584067 [Abstract] [Full Text] [Related]
7. Correlations between the MMPI and the Scale for the Assessment of Positive Symptoms and the Scale for the Assessment of Negative Symptoms in schizophrenic patients. Poreh AM, Chapin K, Rosen MD, Youssef I. J Pers Assess; 1994 Oct; 63(2):275-83. PubMed ID: 7965572 [Abstract] [Full Text] [Related]
9. A Meta-Analysis of the relationship between the Rorschach Ego Impairment Index (EII) and psychiatric severity. Diener MJ, Hilsenroth MJ, Shaffer SA, Sexton JE. Clin Psychol Psychother; 2011 Oct; 18(6):464-85. PubMed ID: 20941796 [Abstract] [Full Text] [Related]
10. [Insight in schizophrenia: assessment of 31 patients with different scales]. Travers D, Levoyer D, Millet B. Encephale; 2008 Jan; 34(1):66-72. PubMed ID: 18514153 [Abstract] [Full Text] [Related]
11. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)]. Bralet MC, Navarre M, Eskenazi AM, Lucas-Ross M, Falissard B. Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451 [Abstract] [Full Text] [Related]
12. A comparison of new and revised Rorschach measures of schizophrenic functioning in a Serbian clinical sample. Dzamonja-Ignjatovic T, Smith BL, Djuric Jocic D, Milanovic M. J Pers Assess; 2013 Dec; 95(5):471-8. PubMed ID: 23844937 [Abstract] [Full Text] [Related]
14. MMPI and Rorschach indices of schizophrenic and depressive diagnoses among adolescent inpatients. Archer RP, Gordon RA. J Pers Assess; 1988 Dec; 52(2):276-87. PubMed ID: 3404390 [Abstract] [Full Text] [Related]
16. Assessing disturbed thinking and cognition using the Ego Impairment Index in older schizophrenia patients: paranoid vs. nonparanoid distinction. Auslander LA, Perry W, Jeste DV. Schizophr Res; 2002 Jan 15; 53(3):199-207. PubMed ID: 11738533 [Abstract] [Full Text] [Related]
17. [Nosologic specificity of psychopathologic findings in schizophrenic and depressed patients]. Schneider F, Böser H, Heimann H, Fus I, Friedrich J. Wien Klin Wochenschr; 1992 Jan 15; 104(3):51-5. PubMed ID: 1570706 [Abstract] [Full Text] [Related]
18. Identity diffusion and psychopathology: comparison between adult psychiatric patients and normals. Benedik E. Psychiatr Danub; 2008 Jun 15; 20(2):123-33. PubMed ID: 18587279 [Abstract] [Full Text] [Related]